DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
In comparison to the flood of emergency use authorizations doled out by the FDA throughout the COVID-19 pandemic, the number of those tests and devices that have gone on to receive full, non-pandemic ...
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today the commercial launch of a new indication for the company’s oXiris set, which ...
Baxter International, a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the US Food and Drug Administration (FDA) for the company’s HF20 Set and ST Set ...
Baxter International Inc., a global leader in acute care, has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for Regiocit, the company’s replacement solution ...